CRISTIAN CONSTANTINESCU: Open Payments
NPI 1922778406 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,149 in 110 payments from 19 companies in 2025. Trend: 2023 $755 · 2024 $1,672 · 2025 $4,149
Consulting: $2,520Food & beverage: $1,629
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 5 | $2,575 |
| ABBVIE INC. | 37 | $397 |
| Biogen, Inc. | 20 | $370 |
| ARGENX US, INC. | 6 | $163 |
| PFIZER INC. | 14 | $143 |
| UCB, Inc. | 4 | $68 |
| Amgen Inc. | 4 | $66 |
| Vanda Pharmaceuticals Inc. | 4 | $64 |
| Neurocrine BioSciences, Inc. | 2 | $40 |
| Lundbeck LLC | 2 | $36 |
Products named: TYSABRI, UBRELVY, VYVGART HYTRULO, QULIPTA, NURTEC ODT, LEQEMBI, UPLIZNA, PONVORY.
Industry payments across NJ — which companies pay providers there.
